131 related articles for article (PubMed ID: 12127691)
1. Deletion of tumor suppressor genes in Chinese non-small cell lung cancer.
An Q; Liu Y; Gao Y; Huang J; Fong X; Liu L; Zhang D; Zhang J; Cheng S
Cancer Lett; 2002 Oct; 184(2):189-95. PubMed ID: 12127691
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of tumor suppressor gene deletion between squamous cell carcinoma and adenocarcinoma lung cancer in Chinese].
An Q; Liu Y; Huang J
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):470-2. PubMed ID: 11859712
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer.
Ho WL; Chang JW; Tseng RC; Chen JT; Chen CY; Jou YS; Wang YC
Cancer Detect Prev; 2002; 26(5):343-9. PubMed ID: 12518864
[TBL] [Abstract][Full Text] [Related]
4. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
Yoshino I; Osoegawa A; Yohena T; Kameyama T; Oki E; Oda S; Maehara Y
Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
[TBL] [Abstract][Full Text] [Related]
6. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
7. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
[TBL] [Abstract][Full Text] [Related]
8. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
[TBL] [Abstract][Full Text] [Related]
9. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
10. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
12. Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients.
Andjelkovic T; Bankovic J; Stojsic J; Milinkovic V; Podolski-Renic A; Ruzdijic S; Tanic N
Transl Res; 2011 Jan; 157(1):19-28. PubMed ID: 21146147
[TBL] [Abstract][Full Text] [Related]
13. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
14. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
Xu XF; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
[TBL] [Abstract][Full Text] [Related]
15. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer.
Tseng RC; Chang JW; Hsien FJ; Chang YH; Hsiao CF; Chen JT; Chen CY; Jou YS; Wang YC
Int J Cancer; 2005 Nov; 117(2):241-7. PubMed ID: 15900585
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
Froudarakis ME; Sourvinos G; Fournel P; Bouros D; Vergnon JM; Spandidos DA; Siafakas NM
Chest; 1998 Apr; 113(4):1091-4. PubMed ID: 9554652
[TBL] [Abstract][Full Text] [Related]
18. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
19. Detection of loss of heterozygosity by high-resolution fluorescent system in non-small cell lung cancer: association of loss of heterozygosity with smoking and tumor progression.
Yoshino I; Fukuyama S; Kameyama T; Shikada Y; Oda S; Maehara Y; Sugimachi K
Chest; 2003 Feb; 123(2):545-50. PubMed ID: 12576379
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.
Ding XJ; Liu MX; Ao L; Liang YR; Cao Y
Virchows Arch; 2011 May; 458(5):561-9. PubMed ID: 21279520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
